Accelerating high value medical solutions

Convergent technologies for faster, more efficient patient care

Technologies to deliver cost and time savings in the NHS

Strong international connections with healthcare organisations

Deep industry expertise to foster technologies with global potential

Atlantic Accelerator and DiagNodus Speed Development of Cancer Screening

November 4 2011

DiagNodus Ltd, a Cambridge-based biomedical early-stage company developing a diagnostic solution for the early detection for colorectal cancer (CRC), has signed an agreement with Atlantic Accelerator (AA) to speed the route to market for DiagNodus’ innovative CRC screening technology – Screen2C™.

Following a competitive pitching round by worldwide healthcare ventures, DiagNodus was selected to join the AA fast-track programme with two AA members joining DiagNodus’ Board.

AA’s fast-track programme provides DiagNodus with the expertise, support and international networks to accelerate the development of and fundraising for Screen2C™, as well as to provide a greater scope for clinical trials, business partnerships and regulatory compliance—the necessary next steps for the early-stage company.

Download the press release here

Leave a Reply

We won't publish or use your email address for marketing purposes. Fields marked * are required.


T +44 (0) 1223 420 252     E